Skip to main content

Cannabis Personal data of 34,000 medical marijuana patients accessed in data breach: NHS

The personal health data of about 34,000 medical marijuana patients were accessed in a data breach of an electronic medical record system used by Sunniva Inc.'s Natural Health Services Ltd. subsidiary.

Graeme Roy/The Canadian Press

The personal health information of about 34,000 medical marijuana patients was accessed in a data breach of an electronic medical record system used by Sunniva Inc.’s Natural Health Services Ltd. subsidiary.

NHS says patients have been informed in the last week of the breach that occurred between Dec. 4, 2018 and Jan. 7.

It says the breach didn’t involve any financial, credit card or social insurance number information since those aren’t collected from patients.

Story continues below advertisement

However, personal injury firm Diamond and Diamond — which has announced a proposed class-action lawsuit against NHS and Sunniva — says it did involve diagnostic results, health-care numbers and personal contact information.

The company, which operates seven clinics in Canada, says it has been working with privacy protection and law enforcement authorities to investigate and respond to the breach.

A dedicated hotline has been set up to field patient inquiries, at 1-888-297-0573.

“We value our patients and understand the importance of protecting personal information and apologize to the patients whose personal information has been improperly accessed and for any frustration or inconvenience that this may cause,” stated NHS president Dr. Mark Kimmins.

This content appears as provided to The Globe by the originating wire service. It has not been edited by Globe staff.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter